We develop routes industrial synthesis
At MOEHS we constantly strive to develop synthetic industrial routesfor new Active Ingredients under criteria of commercial, industrial and intellectual property viability.
Our commercial department is at your disposal to update any details about the status
of our new developments.
At MOEHS we constantly strive to develop industrial synthesis routes for new Active Ingredients under criteria of commercial viability, industrial and intellectual property. Our sales department is at your disposal to update any details about the status of our new developments.
Products in stage of production
| Product Name | CAS N° | Therapeutic Category | Additional Information | DMF / TP |
|---|---|---|---|---|
| EDOXABAN (**) | 1229194-11-9 | Oral anticoagulant | Validation batches | DMF |
| ELAGOLIX (**) | 832720-36-2 | Uterine Fibroids, Endometriosis pain | Validation batches | TP |
| EMPAGLIFLOZIN (**) | 864070-44-0 | Antidiabetic | Validation batches | DMF |
| LASMIDITAN (**) | 439239-90-4 | Acute Antimigraine | Laboratory batches | TP |
| LEMBOREXANT (**) | 1369764-02-2 | Insomnia treatment | Laboratory batches | TP |
| LEVOBUPIVACAINE HCL | 27262-48-2 | Local Anesthetic-Antiarrhythmic | Validation batches | DMF |
| MAVACAMTEN (**) | 1642288-47-8 | Cardiovascular | Laboratory batches | |
| OBETICHOLIC ACID (**) | 459789-99-2 | Liver and gastrointestinal disorders | Laboratory batches | TP |
| PATIROMER CALCIUM SORBITEX (**) | 1260645-52-4 | Hyperkalemia | Laboratory batches | TP |
| RELUGOLIX (**) | 737789-87-6 | Advanced prostate cancer | Laboratory batches | TP |
| REMIMAZOLAM (**) | 308242-62-8 | Sedative | Laboratory batches | US-DMF |
| RIMEGEPANT (**) | 1289023-67-1 | Antimigraine | Laboratory batches | TP |
| RIVAROXABAN (**) | 366789-02-8 | Antibleeding agent | Validation batches | DMF |
| SITAGLIPTIN PHOSPHATE (**) | 654671-77-9 | Antidiabetic | Validation batches | DMF |
| TIRBANIBULIN (**) | 897016-82-9 | Actinic Keratosis | Laboratory batches | TP |
| VERICIGUAT (**) | 1350653-20-1 | Antihypertensive | Laboratory batches | TP |
New Products under testing
| Product Name | CAS N° | Brand Name | Therapeutic Category | Galenic Form |
|---|---|---|---|---|
| MAVACAMTEN (**) | 1642288-47-8 | Cardiovascular | capsules | |
| VERICIGUAT (**) | 1350653-20-1 | Antihypertensive | tablets |
(**) Moehs is working on this compound with experimental aims, exclusively directed to obtain market authorizations of our customers’ generic medicines. We don’t intend to make any activity against any valid patent protection, as well as we will not take charge of third party actions made with the provided compound and without our knowledge against this protection.
